Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Tables)

v3.20.2
Net Income (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted net income (loss) per share:
  Three Months Ended
September 30,
Nine Months Ended
September 30,
  2020 2019 2020 2019
Numerator:        
Net income (loss) applicable to common shareholders $ 2,452  $ 206  $ (11,849) $ (9,411)
Adjustment for gain on fair value of "in the money" warrants (2,545) —  (294) — 
Adjusted net income (loss) used for dilution calculation $ (93) $ 206  $ (12,143) $ (9,411)
Denominator:
Weighted-average number of shares outstanding 8,236  4,996  6,772  4,684 
Effect of dilutive shares:
"In the money" warrants for common stock 143  —  57  — 
Equity awards —  —  — 
Dilutive weighted-average number of shares outstanding 8,379  4,997  6,829  4,684 
Net income (loss) per share applicable to common shareholders
Basic $ 0.30  $ 0.04  $ (1.75) $ (2.01)
Diluted $ (0.01) $ 0.04  $ (1.78) $ (2.01)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table sets forth potential shares of common stock that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive as of the end of each period presented:
  Three Months Ended
September 30,
Nine Months Ended
September 30,
  2020 2019 2020 2019
Options to purchase common stock 532  395  532  396 
Restricted stock units 180  180 
Warrants for common stock 715  571  1,234  571 
Total common stock equivalents 1,427  975  1,946  976